Automated Inspection and Packaging of 36,000 Syringes per Hour

Why It Matters

The deployment proves that high‑volume pharmaceutical production can achieve both speed and full regulatory traceability, reducing risk and operational cost. It signals a shift toward fully automated, compliant end‑of‑line lines across the industry.

Key Takeaways

• 36,000 syringes inspected per hour via integrated robotics.
• Stäubli TX2‑60 and RX160L robots ensure hygienic operation.
• Full 21 CFR Part 11 traceability captured digitally.
• System adapts to multiple tray sizes without retooling.
• Automated reject handling reduces downtime and waste.

Pulse Analysis

Pharmaceutical manufacturers face mounting pressure to boost output while preserving the uncompromising quality standards demanded by regulators and patients. End‑of‑line operations—inspection, labeling, and palletizing—are traditionally bottlenecks, especially when production lines handle tens of thousands of units per hour. Any lapse in traceability or contamination can trigger costly recalls and erode brand trust. Consequently, firms are turning to high‑speed, fully integrated automation that can sustain peak throughput without sacrificing the stringent documentation required by 21 CFR Part 11.

Ward Automation answered this need with a compact robotic cell built around three Stäubli robots, including two TX2‑60 arms for tray handling, vision inspection, and lid sealing, plus an RX160L for palletizing. Dual machine‑vision stations verify syringe count, cap integrity, and label accuracy, while a digital record logs every inspection result, ensuring electronic audit trails. The robots are the Humid Environment (HE) variants, engineered for aggressive wash‑downs, which protects both the equipment and the sterile product. Flexible tooling lets the cell switch between 100‑unit and 160‑unit trays in minutes.

Since commissioning, the cell processes 36,000 syringes per hour with zero manual intervention, dramatically cutting labor costs and cycle time. Real‑time defect detection and automated reject loops keep yield high, while the integrated palletizer eliminates downstream handling risks. The solution demonstrates how modular, software‑driven automation can be retrofitted into existing lines, offering a scalable path for manufacturers expanding capacity or diversifying product portfolios. As the industry embraces Industry 4.0, such end‑to‑end robotic cells will become a benchmark for compliant, high‑volume drug packaging.